Toll-like receptors as targets for enhancing the efficacy of immunotherapy.
Mutschlechner
Sonja
S
Medical University, AKH-Wien, Vienna.
Deifl
Stephan
S
Bohle
Barbara
B
D000276:Adjuvants, Immunologic / Q000008:administration & dosage; D000485:Allergens / Q000008:administration & dosage; D000818:Animals; D003888:Desensitization, Immunologic / Q000379:methods*; D006801:Humans; D006969:Hypersensitivity, Immediate / Q000276:immunology / Q000628:therapy; D008024:Ligands; D051379:Mice; D011994:Recombinant Proteins; D051193:Toll-Like Receptors / Q000378:metabolism*; D016896:Treatment Outcome
D000276:Adjuvants, Immunologic; D000485:Allergens; D008024:Ligands; D011994:Recombinant Proteins; D051193:Toll-Like Receptors